Alliancebernstein L.P. Relay Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 145,251 shares of RLAY stock, worth $486,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares

145,251

Previous 168,281 13.69%

Holding current value

$486,590

Previous $440,000 14.09%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$2.0 - $3.49 $46,060 - $80,374	-23,030 Reduced 13.69%	145,251 $502,000
Q1 2025 May 15, 2025	BUY	$2.62 - $4.92 $78,600 - $147,600	30,000 Added 21.69%	168,281 $440,000
Q3 2024 Nov 14, 2024	SELL	$6.23 - $9.51 $2.65 Million - $4.04 Million	-424,574 Reduced 75.43%	138,281 $979,000
Q2 2024 Aug 14, 2024	BUY	$5.9 - $8.02 $143,086 - $194,501	24,252 Added 4.5%	562,855 $3.67 Million
Q1 2024 May 14, 2024	BUY	$7.5 - $12.07 $3 Million - $4.83 Million	400,322 Added 289.5%	538,603 $4.47 Million
Q4 2023 Feb 14, 2024	SELL	$6.01 - $11.48 $6.63 Million - $12.7 Million	-1,103,194 Reduced 88.86%	138,281 $1.52 Million
Q3 2023 Nov 14, 2023	SELL	$8.24 - $12.97 $5.19 Million - $8.17 Million	-629,555 Reduced 33.65%	1,241,475 $10.4 Million
Q2 2023 Aug 15, 2023	BUY	$9.99 - $18.27 $3.85 Million - $7.04 Million	385,116 Added 25.92%	1,871,030 $23.5 Million
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $3.06 Million - $4.65 Million	-204,107 Reduced 12.08%	1,485,914 $24.5 Million
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $4.06 Million - $6.88 Million	286,596 Added 20.42%	1,690,021 $25.2 Million
Q3 2022 Nov 15, 2022	SELL	$18.07 - $31.37 $8.49 Million - $14.7 Million	-469,839 Reduced 25.08%	1,403,425 $31.4 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $856,019 - $2.24 Million	64,314 Added 3.56%	1,873,264 $31.4 Million
Q1 2022 May 13, 2022	BUY	$20.26 - $32.36 $1.28 Million - $2.05 Million	63,323 Added 3.63%	1,808,950 $54.1 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $10.2 Million - $14.5 Million	391,364 Added 28.9%	1,745,627 $53.6 Million
Q3 2021 Nov 10, 2021	BUY	$29.75 - $37.99 $3.26 Million - $4.16 Million	109,498 Added 8.8%	1,354,263 $42.7 Million
Q2 2021 Jul 30, 2021	BUY	$27.5 - $38.19 $5.27 Million - $7.31 Million	191,474 Added 18.18%	1,244,765 $45.5 Million
Q1 2021 May 06, 2021	BUY	$32.52 - $61.53 $7.56 Million - $14.3 Million	232,522 Added 28.33%	1,053,291 $36.4 Million
Q4 2020 Feb 08, 2021	BUY	$35.51 - $54.03 $4.21 Million - $6.41 Million	118,608 Added 16.89%	820,769 $34.1 Million
Q3 2020 Nov 12, 2020	BUY	$32.81 - $45.1 $23 Million - $31.7 Million	702,161 New	702,161 $29.9 Million

Others Institutions Holding RLAY

# of Institutions

213

Shares Held

172M

Call Options Held

Put Options Held

36.1K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $403M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Relay Therapeutics, Inc. Transaction History